The worlds pace of meat consumption is placing a significant strain on the environment. Many studies show that eating less meat is just as crucial to slowing down global warming as using solar panels and zero-emissions vehicles. Animal farming generates an obscene amount of greenhouse gas emissions.
Thats why the demand for alternatives to animal meat has surged. Consumers are concerned about the environment and animal welfare. As a result, two choices are rising in popularity: plant-based meats and cultured meats. The meat alternatives market is estimated to reach $140bn (104bn) within the next decade. Thats about 10% of the $1.4tn global meat industry.
Plant-based foods emissions are 10 to 50 times smaller than those from animal products. Cultured (lab-grown) meats generate up to 96% fewer emissions, use up to 96% less water, and require 99% less land than traditionally farmed meats. And no animals need to be slaughtered in the process.
According to the Straits Times (ST), Esco Aster, a home-grown contract development and manufacturing organization, has already begun operations at its commercial facility in Singapore. The facility, located in the 8-story Ayer Rajah Crescent, produces chicken products via cell culture instead of slaughter. On July 28, it was given SFA approval and began making cell-cultured chicken a world first.
Esco Asters facility paves the way for more protein alternatives to enter the Singapore market and enhance the nations food security. In December last year, the Singapore Food Agency (SFA) was the worlds first regulatory authority to approve the sale of cultured meat chicken nuggets from Eat Just after it was deemed safe for consumption.
On April 22 (Earth Day), Eat Just joined forces with Foodpanda, Asias leading food, and grocery delivery platform, to launch the worlds first home delivery of cell-cultured meat. Diners were able to place orders of three GOOD Meat Cultured Chicken dishes via the Foodpanda app, with each order boxed in sustainable bamboo packaging and delivered by e-bike. In addition, eat Justs Good Meat cultivated chicken is now available via the delivery platform from the Cantonese restaurant Madame Fan at JW Marriott Singapore South Beach.
Before this SFA approval to produce cultured chicken for commercial use, Eat Justs cultured chicken nuggets were not allowed to be manufactured in Singapore. However, a spokesman for SFA noted: This is the same cultured chicken which was previously approved by SFA in 2020.
Cultured meat is meat products made from growing animal cells in a bioreactor like the tanks used in brewing beer instead of slaughtering real-life chickens. This method is considered a more sustainable approach to producing meat since large volumes can be made using less land and labor.
Esco Aster, a subsidiary of the Esco Lifescience Group, has supplied tools and technology, including bioreactors, to companies in the alternative proteins industry. The firm also offers manufacturing services for vaccine development and cell- or gene therapy, among others. Esco Asters chief executive Lin Xiangliang told ST on September 15 that, thanks to this professional background, Esco Aster designed the manufacturing facility to the standards required by SFA.
In Singapore, companys who wish to produce cultured meat products must first conduct and submit safety assessments of the products for SFAs review before theyre allowed to sell them. These assessments comprise potential food safety risks, such as toxicity and production method safety. In addition, companies must also provide detailed information on the materials used in the manufacturing processes and how these are regulated to prevent food safety risks. Finally, firms that plan to manufacture these approved products in Singapore must obtain a separate SFA license.
The SFA spokesman explained:
If companies wish to manufacture any already-approved alternative protein products in Singapore, as with any other food, they must obtain an SFA license and are subject to checks by SFA of the premises, systems, and products. SFA will also inspect and sample the product for testing, just as we do for other imported and locally manufactured food products.
The only cultured meat product approved for sale in Singapore is Eat Justs cultured chicken bites. We have multiple production partners for Good Meat and look forward to growing our business in Singapore, which will be a manufacturing hub for the company, added a spokesman for Eat Just.
According to the Eat Just spokesman, regulatory authorities in other jurisdictions, such as the Middle East and the United States, are assessing Eat Justs Good Meat cultivated chicken. Eventually, the firm plans to set up a cultivated meat facility in the Middle East and Northern Africa.
According to the FAO, alternative proteins are gaining interest globally as an increasing number of consumers become conscious about the massive carbon footprint of nurturing livestock for food, which produces roughly 15% of global GHG emissions.
While this is an emerging field, with Singapore the only country approved to sell such products, many cultured meat consumer goods are already being made in smaller facilities and laboratories at a smaller scale. However, a commercial plant in Singapore could enable the production of such alternative proteins to be scaled up more rapidly once theyre approved for sale, bringing costs down.
Mirte Gosker, the acting managing director at The Good Food Institute Asia Pacific a non-profit that champions meat alternatives, highlighted:
This move is the clearest sign yet that the Lion City is all in on scaling up alternative proteins and driving Asias runaway lead in food technology. Other nations would be wise to follow Singapores example by investing in this smarter way of making meat before they get left behind.
Around 20 companies producing lab-grown meat and plant-based protein have set up bases in Singapore over the last couple of years.
The country currently imports over 90% of its food from more than 160 countries, and the pandemic has affected vital global supply chains. However, the government aims to have 30% of Singapores nutrition from domestic sources by 2030.
Singapore is the first country to develop a regulatory framework to bring cultured meat to the market. In May, the Future Ready Food Safety Hub opened to help companies navigate the approval process to accelerate their products onto consumers plates.
The city-island-nation with almost no livestock and hardly any agricultural land hopes to become a meat producer eventually. Singapore provides a path to commercialization. It is the only place in the world where thats possible, commented Carrie Chan, the founder, and CEO of Avant Meats, a Hong Kong-based company developing cultured fish in Singapore.
The first cell-based meat firm in Singapore, Shiok Meats, has unveiled the worlds first lab-grown crab meat at a recent tasting event in Singapore. Shiok Meats creates authentic seafood from a small number of animal cells in a laboratory, a technique used to produce food without relying on industrial fishing.
Dr. Ka Yi Ling and Dr. Sandhya Sriram, the Co-founders of Shiok, said in a joint statement:
We are ecstatic that we were able to showcase the first-ever cell-based crab meat that we produced in our facility. We are humbled by the support and enthusiasm of our team, investors, and collaborators. In this exclusive tasting event, we invited some key stakeholders in the food and alternative protein industry.
For the event, at Kebaya, an eclectic restaurant in Bukit Timah, Shiok Meats partnered with local chef Jos Luis Del Amo to prepare several dishes highlighting the companys innovative cell-based crab.
Two of these dishes mixed Shioks cell-based crab with other innovative products to create:
Chef Del Amo said:
The ingredient is really versatile, and it works well across different cuisines, including local Asian dishes. Also, its fantastic that we can now prepare delicious meals with sustainable crab meat.
Now that Shiok has championed the flavor of crab, its working on perfecting the texture of the crustacean by introducing scaffolding during the growth process. The company is also exploring how it could lower the production costs of making seafood via this method and aims to commercialize its crab meat by 2023.
Shioks road to market will be cleared by regulatory hurdles it would likely face in other countries, now that Singapore has been granted regulatory approval to cell-based meat when it approved the sale of Eat Justs GOOD Meat Cultured Chicken.
Before revealing its cell-based crab to the public, Shiok produced meat from other crustaceans using its cell-based technology. Shiok unveiled its cell-based shrimp served in Tom Yum Soup and its cell-based lobster in Lobster Potato Chips during the latest tasting event.
The company uses proprietary technology to isolate stem cells from shrimp, crab, and lobster to produce the meat. Then, the harvested cells are grown in a nutrient-rich environment (like a greenhouse), and after 4 to 6 weeks, the result is real crustacean meat.
This new way of producing seafood meat solves the increasing global demand for traditionally caught seafood. Unfortunately, the global industrial fishing industry destroys marine ecosystems and wreaks havoc on the environment. Meanwhile, the crustacean industry is responsible for 22% of fishing-related GHG emissions, despite making up only 6% of global catch landings.
Dr. Sriram and Dr. Yi Lin explained:
Our mission is to develop cell-based crustacean meats that are contributing towards a cleaner and healthier seafood industry and solving for the inefficiencies around global protein production. We are working very hard on making sure that our products are delicious, healthy, and affordable in the long run.
Besides reducing emissions and preventing overfishing, one of the many benefits of growing seafood from cells as opposed to catching it, is that the process can be carried out in landlocked areas.
However, two significant obstacles are standing in the way of Singapores dreams of animal-free meat self-sufficiency. The first is cost. For example, Shiok Meats shrimp paste costs the company about US$5,000 to produce one kilogram of the paste, far from commercially viable.
In addition, most lab-grown cells are nourished with a growth medium, often fetal bovine serum (FBS), extracted from aborted calves. FBS is used widely in the biotech industry; its production is highly regulated worldwide. However, its supply is limited, and its cost is outrageous: 500 milliliters costs approximately US$500.
Most importantly, an industry based on producing meat without animal suffering should not include ingredients from slaughterhouses. But thats precisely where FBS comes from.
When a cow arriving for slaughter is pregnant, that cow is slaughtered and bled; then, the fetus is removed and brought into a blood collection room. The fetus, kept alive during the following procedure to ensure blood quality, has a needle jabbed into its heart. Next, its blood is drained, which usually takes around five minutes until the fetus dies. This blood is subsequently refined, and the resulting extract is FBS. Millions of fetuses are slaughtered this way. FAO estimated that the percentage of slaughtered pregnant dairy cows is between 17 and 31%.
There are alternatives to FBS People for the Ethical Treatment of Animals has compiled a list of 74 potential cell culture alternatives, but almost all are cell-type specific. In contrast, FBS is a universal growth medium, meaning you can take nearly any cell type, throw it into a petri dish with FBS, and the cells will grow.
The second big question for the city-island-nation is whether domestic production will reduce its reliance on foreign supply. Substances like FBS are imported, as are the ingredients needed for Singapores booming plant-based protein market.
On April 26, Bhler, a global leader for food processing solutions, and Givaudan, a leading global company in Taste and Wellbeing, opened a new Protein Innovation Center in Singapore. It serves as an R&D facility for plant-based protein companies that want to produce new recipes and learn how to industrialize them. However, yet again, most ingredients need to be shipped into the country.
One potential solution to Singapores reliance on foreign ingredients is food waste. There are already companies making vegan meat, dairy, and protein from food waste. Another way to make protein in a factory is via fermentation. Usually, the fungus or microbes that produce such protein would be fed with imported glucose; however, scientists are exploring whether they are partial to old yeast from Singapores breweries or coffee grounds from its cafes.
The future of Singapores blossoming protein industry may be a mix of animal cells and vegetables. The trend we see right now is a mix of cultured meat and plant-based protein. Full cultured meat in the market is far away, but animal proteins help enhance the texture of plant-based products, explained Adrien Beauvisage, Buhlers president for Southeast Asia.
- Here's Why Longeveron Is Surging Today - Motley Fool - December 4th, 2021
- Global Regenerative Medicine Partnering Report/Directory 2021: Terms and Agreements for 1600 Deals 2014-2 - Benzinga - December 4th, 2021
- CAR T-Cell Therapy Market is anticipated to reach US$ 2.8 Bn by 2031 - PRNewswire - December 4th, 2021
- Stem-cell implant prototypes pave the way towards life-long treatment for type 1 diabetes - ZME Science - December 3rd, 2021
- Certain Patients With Heart Failure May Benefit From Stem Cell Therapy - Pharmacy Times - December 3rd, 2021
- Humanigen Announces Conference Call and Webcast to Discuss Lancet Respiratory Medicine Publications and Provide a Corporate Update - Yahoo Finance - December 3rd, 2021
- Roundtable Discussion: Usmani and Participants Review Using Transplant and Combination Therapy in a Patient With Newly Diagnosed Multiple Myeloma -... - December 3rd, 2021
- Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship - DocWire News - December 3rd, 2021
- Reality of universal cancer prevention & cure - BSA bureau - December 3rd, 2021
- World Aids Day Improving the lives of everyone affected by HIV - QMUL - December 3rd, 2021
- Seres Therapeutics Announces First Patient Enrolled in Phase 1b Study of SER-155, an Investigational Microbiome Therapeutic to Reduce the Risk of... - December 3rd, 2021
- AVROBIO Presents Clinician Experience with FAB-GT Clinical Trial and Updated Safety Data for Investigational Gene Therapies in Fabry Disease and... - November 28th, 2021
- The questions surgical robots still need to answer - Becker's Orthopedic & Spine - November 24th, 2021
- Holiday Gift Guide 2021: The Best Wellness And Self-Care Essentials For Travel - Forbes - November 24th, 2021
- Investigating pathogens and their life cycles, for the benefit of society - MIT News - November 24th, 2021
- Mitigating Toxicities Will Position BCMA for Role in Triple-Class Refractory Multiple Myeloma - OncLive - November 24th, 2021
- Human Primary Cells Market 2021 | Know the Latest COVID19 Impact Analysis and Strategies of Key Players: Lonza, Thermo Fisher Scientific,... - November 21st, 2021
- Researcher Works for Diversity, Inclusion in Sciences, One Journal at a Time - Lab Manager Magazine - November 18th, 2021
- Raw Marijuana Won't Get You Stoned, But It Does Have Some Interesting Benefits - Benzinga - Benzinga - November 16th, 2021
- The 18 Best New November 2021 Skin-Care Launches That Deserve a Spot in Your Routine - Allure - November 16th, 2021
- Dermarolling Your Scalp Is Proven to Increase Hair Growth and Thickness Here's How to Do It - Yahoo Lifestyle - November 15th, 2021
- Stem Cell Therapy for Heart Failure Reduces CV Events, Death in Select Patientsbut not Hospitalization - AJMC.com Managed Markets Network - November 15th, 2021
- JASPER THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com - November 15th, 2021
- Week In Review: Zai Lab Announces Two In-Licensings With Total Value Of $800 Million - Seeking Alpha - November 15th, 2021
- Beam gets green light to begin first clinical test of base editing - BioPharma Dive - November 15th, 2021
- GlycoMimetics GMI-1359 Data Selected for Presentation at 63rd American Society of Hematology (ASH) Annual Meeting and Exposition - Galveston County... - November 15th, 2021
- Jasper Therapeutics to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference - GlobeNewswire - November 11th, 2021
- Biotech Companies are Expanding the Frontiers of Engineered Cell Therapy - BioSpace - November 11th, 2021
- Fate Therapeutics Announces Abstract Highlighting FT538 and - GlobeNewswire - November 11th, 2021
- Poseida Therapeutics to Present Preclinical Data Highlighting Fully Allogeneic CAR-T Product Candidates at the Society for Immunotherapy of Cancer... - November 11th, 2021
- Affimed Reports Third Quarter 2021 Financial Results and Highlights Operational Progress - KULR-TV - November 11th, 2021
- Jasper Therapeutics to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference - Yahoo Finance - November 9th, 2021
- CELLECTAR BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com - November 9th, 2021
- Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic - PRNewswire - November 9th, 2021
- Technology set to redesign the future of food as agriculture moves towards net zero - ABC News - November 9th, 2021
- MAGENTA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - marketscreener.com - November 5th, 2021
- Magenta Therapeutics Announces Data Presentations Related to its Mobilization and Conditioning Programs at the 2021 American Society of Hematology... - November 5th, 2021
- 15 Best Peptide Skin-Care Products 2021 for Smoother, Firmer, and Plumper Skin - Allure - November 5th, 2021
- Atara Biotherapeutics to Present Eight Abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting, Including First Presentation of... - November 5th, 2021
- CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results - GlobeNewswire - November 5th, 2021
- Fate Therapeutics Announces Eight Presentations at the 2021 ASH Annual Meeting - The Bakersfield Californian - November 5th, 2021
- STEMTECH CORPORATION (OTC:GNTW) ANNOUNCES APPOINTMENT OF SANDRA KAZICKAITE TO THE ROLE OF VICE PRESIDENT OF GLOBAL PERFORMANCE - Yahoo Finance - November 3rd, 2021
- Assessing the benefits of stem cell research (column) - LNP | LancasterOnline - November 1st, 2021
- How to Test for Leukemia: What Are My Options? - Healthline - November 1st, 2021
- Exposed: The Plague Of Fake Medical Trials Putting Lives In Danger - Todayuknews - Todayuknews - November 1st, 2021
- To Reduce Stress and Boost Energy, Try Maca Root - The Beet - November 1st, 2021
- In Vitro Toxicology Testing Market Outlook 2021 Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by... - November 1st, 2021
- Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat - Business Wire - November 1st, 2021
- Stem Cell Diseases: What Can Stem Cells Cure | stemcela.com - October 30th, 2021
- The Cost Of Stem Cell Therapy in 2021 | BioInformant - October 30th, 2021
- NIH Guidelines for Human Stem Cell Research | STEM Cell ... - October 30th, 2021
- Fi Europe 2021 innovation finalists mirror mega trends of plant based and sustainability - FoodNavigator.com - October 30th, 2021
- Types of Oncology Drugs - Healthline - October 28th, 2021
- Medical Innovation In Pet Healthcare Is Taking Things Up a Notch - Entrepreneur - October 28th, 2021
- BIOHAVEN ENROLLS PHASE 1A/1B CLINICAL TRIAL OF BHV-1100, LEAD ASSET FROM ITS ARM (ANTIBODY RECRUITING MOLECULE) PLATFORM, IN COMBINATION WITH NK CELL... - October 28th, 2021
- Researchers discover a way to increase the effectiveness of antibiotics - EurekAlert - October 28th, 2021
- Fresh Bros: Exploring the Top Five Health Benefits of Turmeric Extract with BioPerine - GlobeNewswire - October 28th, 2021
- All hopes to save the northern white rhinos now rest on a single female - ZME Science - October 23rd, 2021
- AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1 - StreetInsider.com - October 21st, 2021
- CDMO: The Rise of End-to-End Services - Marketscreener.com - October 21st, 2021
- MeiraGTx Announces the Presentation of Two Novel Inherited - GlobeNewswire - October 21st, 2021
- Current status of drug repositioning in hematology - DocWire News - October 19th, 2021
- Is Fresh Breast Milk Better for Preemies Than Pumped and Stored? - UMass News and Media Relations - October 19th, 2021
- Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem... - October 19th, 2021
- Headband Could Beat Insomnia By Zapping The Brain While Sufferers Wear It For 20 Minutes At Bedtime - - Todayuknews - October 19th, 2021
- BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization -... - October 17th, 2021
- Misinformation on stem cell treatments for COVID-19 linked to overhyped science, researchers argue - EurekAlert - October 17th, 2021
- FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With Early Non-Small Cell Lung Cancer - BioSpace - October 17th, 2021
- Nic Chapman: my MS battle and the treatment that's given me hope - The Times - October 17th, 2021
- Dream Body Clinic Stem Cell Therapy Stem Cells HGH - October 13th, 2021
- Hematopoietic Stem Cells - October 13th, 2021
- 3D printing: Healthcare insiders' view on the tech - Verdict - October 13th, 2021
- Top 10 Best Stem Cell Supplement Brands - Healthtrends - October 13th, 2021
- Mitochondrial superoxide dismutase overexpression and low oxygen conditioning hormesis improve the performance of irradiated sterile males |... - October 13th, 2021
- Researchers uncover how cancer cells use sugar residue to evade the immune system - News-Medical.net - October 13th, 2021
- The science and practicality of cultured meat The Stute - The Stute - October 11th, 2021
- Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Le - Benzinga - October 11th, 2021
- Want To Support Healthy Bones? It's Time To Get Your Vitamin D In Check - mindbodygreen.com - October 11th, 2021
- Joint : Why Breast Cancer Awareness Matters, and How to Get It Done - marketscreener.com - October 11th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - KY3 - October 7th, 2021